Pharmacovigilance is changing quietly but fundamentally. You can feel it in the way adverse event reports move faster through systems, in how signals surface earlier, and in how dashboards now carry insights that once took weeks of manual review. Machine learning, natural language processing, and
Read More
The Role of Ethical Oversight and Algorithmic Bias in Automated Pharmacovigilance
































































